| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Wilbur James is a Chief Commercial Officer at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sell | 3,464 | $43.34 | $150,118.33 | -4.0% | +9.5% | -69.3% | |
| Nov 20, 2023 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sell | 14,718 | $42.09 | $619,493.87 | -14.5% | +9.3% | -68.7% | |
| Aug 22, 2023 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sell | 9,699 | $45.78 | $444,030.89 | -8.7% | -6.2% | -50.3% | |
| May 23, 2023 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sell | 316 | $55.07 | $17,400.63 | -0.3% | -13.1% | -54.9% |